在不补偿性肝硬化中使用的新型预后生物标志物:系统性审查和元分析
Adrià Juanola1,2,3, Ann Thu Ma4, Koos de Wit5
1Liver Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
Gut
|October 26, 2023
概括
新型生物标记物,如介乐金-6 (IL-6),尿中性粒细胞凝酶相关的卡林 (uNGAL) 和素,在预测无补偿性肝硬化患者90天死亡率方面表现有前途. 这些标记器可能会比单独的MELD得分提供更好的准确性.
科学领域:
- 肝病学和临床生物化学
- 生物标志物发现和验证
- 在肝脏疾病的预后建模.
背景情况:
- 减补性肝硬化带来了高死亡率,现有的预后得分,如MELD在不同患者群体中可能表现不佳.
- 准确的预后对于及时干预和管理晚期肝病患者至关重要.
- 新的生物标志物正在被研究,以提高死亡率和不补偿性肝硬化症并发症的预测.
结论:
- 新型生物标志物,特别是IL-6, uNGAL和copeptin,显示出潜在的潜力,可以显著提高脱补偿性肝硬化患者的预后准确性.
- 与当前的标准MELD分数相比,这些生物标志物可以提供更精确的死亡风险评估.
- 需要进一步的研究和临床验证,以将这些生物标志物纳入常规患者管理中.
关键词:
肝硬化是肝硬化的一种疾病.
相关概念视频
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
99
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
99
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
174
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
174
01:28Esophageal Varices-II: Clinical Features and Management
73
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
73
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
19
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
19
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
117
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
117